Exclusively distributed in North America by Core Oncology, Visicoil™ linear fiducial soft tissue markers are used to localize organs, tumors and tumor beds for image-guided radiation therapy. Click here to view brochure.

Product Features

The clinical success of focused, dose-delivery procedures such as intensity modulated radiation therapy (IMRT) and conformal radiation therapy (CRT) is based on the accuracy of target identification and precise patient positioning. Visicoil markers allow for accurate tumor localization, using a variety of visualization techniques, and help focal radiotherapy procedures through the following:

Key benefits are:
Higher doses to the tumor and periphery Accurate daily patient positioning Dose escalation in a given session	Real-time targeting of tumors and tumor beds Image-fusion between various visualization modes (CT, MRI, Ultrasound)

Visibility

Visicoil is visible under all common imaging modalities and is ideal for image fusion procedures. (Click on images to view larger image)

TRUS CT/kV   X-Ray   MRI DRR   MV

Delivery Options

Visicoil is available in three distinct delivery options. (Mouse over headings to view details)

Applications

Visicoil is a general-purpose implanted fiducial marker. The marker is indicated for use to radiographically mark soft tissue for future therapeutic procedures, per the US FDA approved 510(K).

By design, the Visicoil markers are made to facilitate patient positioning in focused field radiation therapies such as intensity modulated radiation therapy (IMRT), conformal radiation therapy (CRT) and proton therapy, etc. The marker also helps define the boundary of the prostate in brachytherapy, HDR and assists in image fusion between MRI and CT or CT and ultrasound

Currently, the device has been developed for use in marking the prostate and periprostatic tissue. Visicoil's unique design allows for placement in more delicate tumors and tumor beds such as: Cervix, Lung, Pancreas and Breast.

 

 

* Implantation techniques in organ sites other than prostate not currently validated by RadioMed. Coil lengths indicated are suggested lengths based on early clinical work. Specific coil length/diameter needs to be determined by the implanting physician.